logo GSK

Results of voting at AGMs

Issued - Wednesday 25th May 2005, London - LSE Announcement
Voting on the resolutions put to each AGM is on a poll rather than by a show of hands. The results of the poll are announced to the London Stock Exchange, via the Regulatory Information Service, as soon as practicable after the AGM. They are also published on this page.

Results of AGM

GlaxoSmithKline (GSK) announces that at today's Annual General Meeting all resolutions, including those electing
and re-electing Board members, were passed by shareholders.

The following table shows the votes cast for each resolution:

  Resolution Total Votes For* % Total Votes Against % Total Votes Cast Abstentions **
1. Adoption of Financial Statements
3,906,841,624
98.79%
47,758,594
1.21%
3,954,600,218
175,150,362
2. Approval of the Remuneration Report
3,800,433,274
95.40%
183,067,146
4.60%
3,983,500,420
146,250,160
3. Election of Sir Christopher Gent
4,099,468,431
99.62%
15,431,801
0.38%
4,114,900,232
14,850,348
4. Election of Sir Deryck Maughan
4,104,142,353
99.75%
10,428,930
0.25%
4,114,571,283
15,179,297
5. Election of Mr J Heslop
4,100,614,116
99.66%
14,129,375
0.34%
4,114,743,491
15,007,089
6. Re- election of Dr J- P Garnier
4,099,153,866
99.61%
15,882,823
0.39%
4,115,036,689
14,713,891
7. Re- election of Sir Ian Prosser
4,103,392,185
99.73%
11,267,847
0.27%
4,114,660,032
15,090,548
8. Re- election of Dr R Schmitz
4,103,662,925
99.74%
10,802,992
0.26%
4,114,465,917
15,284,663
9. Re- election of Dr L Shapiro
4,096,777,184
99.57%
17,647,353
0.43%
4,114,424,537
15,326,043
10. Re- appointment of Auditors
4,055,015,241
99.48%
21,364,410
0.52%
4,076,379,651
53,370,929
11. Remuneration of Auditors
4,098,763,019
99.62%
15,675,183
0.38%
4,114,438,202
15,312,378
12. Authorise donations to EU Political Organisations and incur EU Political Expenditure
4,024,458,274
98.08%
78,854,300
1.92%
4,103,312,574
26,438,006
13. Disapplication of pre- emption rights***
4,067,878,763
99.05%
39,147,397
0.95%
4,107,026,160
22,724,420
14. Authority for the Company to purchase its own shares***
4,106,321,241
99.80%
8,129,177
0.20%
4,114,450,418
15,300,162
15. Insertion of new Articles 48A into the Articles of Association***
4,088,185,649
99.84%
6,721,259
0.16%
4,094,906,908
34,843,672
16. Deletion of Article 154.2 of the Articles of Association***
4,087,140,974
99.79%
8,426,154
0.21%
4,095,567,128
34,183,452
17. Amendment to Article 81 of the Articles of Association***
4,090,361,524
99.88%
5,032,818
0.12%
4,095,394,342
34,356,238

 

Notes:
* Includes discretionary votes.
** An abstention is not a vote in law and is not counted in the calculation of the proportion of votes "For" or
"Against" a resolution.
*** Indicates Special Resolutions requiring a 75% majority


The following table provides further relevant information:

 
GlaxoSmithKline's
Fifth AGM (2005)
GlaxoSmithKline's
Fourth AGM (2004)
Issued share capital
(excluding Treasury Shares)
5,852,415,354
5,921,564,431
Total votes cast and abstentions lodged as a % of GSK's issued share capital (excluding Treasury Shares).
70.56%
66.75%
Total shareholder population.
209,029
230,939
Total number of proxies lodged.
16,156
17,400
% of shareholders who lodged proxies.
7.73%
7.53%
Number of shareholders, corporate representatives and proxies who attended the AGM
286
349

S M Bicknell
Company Secretary
25th May 2005

Back to top